相关实验视频
Updated: Sep 12, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
针对P-选择因/PSGL-1通路:发现了针对血栓炎症疾病的疾病修饰疗法
Samira Escopy1, Elliot L Chaikof1,2,3
1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
一个关键的免疫分子P-selectin与PSGL-1相互作用,导致各种疾病. 针对这种途径的抑制剂对炎症和血栓性疾病具有治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- P-选择素是一种细胞粘附分子,对先天免疫至关重要.
- 它在激活的血小板和内皮细胞上迅速表达.
- P-选择素及其连接物PSGL-1与许多疾病有关.
研究的目的:
- 审查P-selectin/PSGL-1通路抑制剂的发展情况.
- 在临床前和临床研究中评估这些抑制剂的治疗潜力.
主要方法:
- 对P-选择因抑制剂的临床前研究的综述.
- 对生物和小分子抑制剂的临床试验的分析.
- 对炎症和血栓性疾病的治疗疗效的评估.
主要成果:
- 在开发P-选择素和PSGL-1抑制剂方面取得了显著进展.
- 在各种疾病模型中证明了治疗潜力.
- 一些候选抑制剂的临床试验正在进行中.
结论:
- P-selectin/PSGL-1通路是一个可行的治疗点.
- 抑制剂为炎症和血栓状况提供了有前途的治疗策略.
- 需要进一步的研究和临床评估.
更多相关视频
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Venous Thrombosis III: Interprofessional Care
Intracellular Signaling Affects Focal Adhesions
Some...